BioInsights - Modality/platform development trends - spotlight

IMMUNO-ONCOLOGY INSIGHTS

Modality/platform development trends

David Dilillo
Guest Editor:
David Dilillo, Senior Director, Immuno-Oncology at Regeneron Pharmaceuticals
April 2023

Modality/platform development trends